Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 10, 2010 - Issue 5
Submit an article Journal homepage
37
Views
7
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Cost–effectiveness of prostate cancer chemoprevention among high-risk men

Steven B Zeliadt VA Health Services Research & Development Service, Department of Veterans Affairs Medical Center, 1100 Olive Way, Suite 1400, Seattle, WA 98101, USA. [email protected]; VA Health Services Research & Development Service, Department of Veterans Affairs Medical Center, 1100 Olive Way, Suite 1400, Seattle, WA 98101, USA. [email protected]
&
Scott D Ramsey Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Pages 505-508 | Published online: 09 Jan 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Spiros D Garbis & Paul A Townsend. (2013) Proteomics of human prostate cancer biospecimens: the global, systems-wide perspective for Protein markers with potential clinical utility. Expert Review of Proteomics 10:4, pages 337-354.
Read now

Articles from other publishers (6)

Christopher R. Flowers & Scott D. Ramsey. (2018) What Can Cost-Effectiveness Analysis Tell Us About Chimeric Antigen Receptor T-Cell Therapy for Relapsed Acute Lymphoblastic Leukemia?. Journal of Clinical Oncology 36:32, pages 3183-3185.
Crossref
Ricardo Romão Nazário Leão, Aryeh Joshua Price & Robert James Hamilton. (2017) Germline BRCA mutation in male carriers—ripe for precision oncology?. Prostate Cancer and Prostatic Diseases 21:1, pages 48-56.
Crossref
. (2013) Current World Literature. Current Opinion in Oncology 25:3, pages 325-337.
Crossref
Stephanie R. Earnshaw, Andrew P. Brogan & Cheryl L. McDade. (2013) Model-Based Cost-Effectiveness Analyses for Prostate Cancer Chemoprevention. PharmacoEconomics 31:4, pages 289-304.
Crossref
S B Stewart, C D ScalesJrJr, J W Moul & S D Reed. (2012) Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?. Prostate Cancer and Prostatic Diseases 15:4, pages 380-385.
Crossref
Marcelo Langer Wroclawski, Cynthia Kuk, Antonio Finelli, Neil E Fleshner & Alexandre R Zlotta. (2011) Chemoprevention of prostate cancer: is there evidence from clinical trials?. Clinical Investigation 1:9, pages 1257-1268.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.